Bell Michael Brian 4
4 · Guardant Health, Inc. · Filed Mar 13, 2026
Research Summary
AI-generated summary of this filing
Guardant Health (GH) CFO Michael Bell Receives RSU Award
What Happened
Michael Brian Bell, Chief Financial Officer of Guardant Health, was granted 26,582 restricted stock units (RSUs) on March 11, 2026. The award is reported as a derivative grant at $0.00 (no cash purchase); the RSUs convert to shares as they vest rather than being an immediate stock purchase or sale.
Key Details
- Transaction type/date: Award of RSUs on 2026-03-11 (reported on Form 4 filed 2026-03-13).
- Shares/price: 26,582 RSUs granted; reported acquisition price $0.00 (standard for RSU grants).
- Shares owned after transaction: Not specified in this Form 4 (not reported).
- Vesting (footnote F1): 33% vests on April 1, 2027; remaining 67% vests in equal quarterly installments over the subsequent two years.
- Footnote F2: Not applicable for RSUs.
- Filing timeliness: Form 4 was filed on 2026-03-13 for a 2026-03-11 grant — appears timely under normal Form 4 reporting rules.
Context
RSU grants are a common form of executive compensation and do not involve an immediate cash outlay or open-market purchase; they only convert to actual shares if and when vesting conditions are met. Such awards are routine and reflect compensation, not an immediate market position change by the insider.
Insider Transaction Report
Form 4
Bell Michael Brian
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
[F1][F2]2026-03-11+26,582→ 26,582 totalExercise: $0.00→ Common Stock (26,582 underlying)
Footnotes (2)
- [F1]This represents a restricted stock unit award granted on March 11, 2026 that vests over a three-year period. 33% of the shares subject to such award will vest on April 1, 2027 and the remaining 67% of the shares vests in equal quarterly installments over the remaining two-year period thereafter.
- [F2]Not applicable for Restricted Stock Units.
Signature
/s/ John G. Saia, as attorney-in-fact for Michael Brian Bell|2026-03-13